Vivera Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Vivera Pharmaceuticals has a total of 25 patents globally, out of which 6 have been granted. Of these 25 patents, more than 84% patents are active. The United States of America is where Vivera Pharmaceuticals has filed the maximum number of patents, followed by Australia, Canada and United Kingdom. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vivera Pharmaceuticals.

Vivera Pharmaceuticals was founded in 2018. Vivera Pharmaceuticals is a biopharmaceutical organization. The company offers advanced diagnostics, medical supplies, pharmaceuticals, medical devices, medical technologies, and neurosciences.

Do read about some of the most popular patents of Vivera Pharmaceuticals which have been covered by us in this article and also you can find Vivera Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vivera Pharmaceuticals patent portfolio.

How many patents does Vivera Pharmaceuticals have?

Vivera Pharmaceuticals has a total of 25 patents globally. These patents belong to 5 unique patent families. Out of 25 patents, 21 patents are active.

How Many Patents did Vivera Pharmaceuticals File Every Year?

Vivera Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantVivera Pharmaceuticals Applications FiledVivera Pharmaceuticals Patents Granted
20232
202242
202192
20206
20195
20181

How many Vivera Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Vivera Pharmaceuticals Patent Portfolio

How Many Patents did Vivera Pharmaceuticals File in Different Countries?

Vivera Pharmaceuticals Worldwide Patent Filing

Countries in which Vivera Pharmaceuticals Filed Patents

CountryPatent
United States Of America16
Australia2
Canada2
United Kingdom2
Israel1

Where are Research Centers of Vivera Pharmaceuticals Patents Located?

The Research Center of Vivera Pharmaceuticals is in the United States of America.

Best Vivera Pharmaceuticals Patent

US20230104820A1 is the most popular patent in the Vivera Pharmaceuticals portfolio. It has received 1 citation so far from company like PrinterPrezz.

What Percentage of Vivera Pharmaceuticals US Patent Applications Were Granted?

Vivera Pharmaceuticals (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 4 have been granted leading to a grant rate of 100%.

Below are the key stats of Vivera Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Vivera Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Genius Patent Apc12100%

List of Vivera Pharmaceuticals patents

Vivera Pharmaceuticals PatentsTitle
US11594149B1Speech Fluency Evaluation And Feedback
US11450420B2Secure Smart Dosing System With Automated Delivery, Measurement, And Management For Pills
US11406728B2Self-Contained, Portable, Sanitization Device And Telemedicine Station
US11090449B2Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management
US11083850B2Secure Smart Dosing System With Automated Delivery, Measurement, And Management
US20230114360A1Sublingual Delivery For Mitigation Of Side Effects Associated With Zicronapine
US20230104820A1Self-Contained, Portable, Sanitization Device And Telemedicine Station
US20220168226A1Sublingual Delivery For Mitigation Of Side Effects Associated With Metformin
US20220117900A1Sublingual Delivery For Mitigation Of Side Effects Associated With Vortioxetine
US20220117901A1Sublingual Delivery For Mitigation Of Side Effects Associated With Brexpiprazole
US20220096387A1Sublingual Delivery For Mitigation Of Side Effects Associated With Lurasidone
US20220062189A1Sublingual Delivery For Mitigation Of Side Effects Associated With Sildenafil Citrate
US20220023223A1Sublingual Delivery For Mitigation Of Side Effects Associated With Blonanserin
US20210401758A1Sublingual Delivery For Mitigation Of Side Effects Associated With Trazodone
US20210401757A1Sublingual Delivery For Mitigation Of Side Effects Associated With Olanzapine And Metformin
GB2591888BSmart Inhaler Device With Automated Dose Delivery, Measurement, And Management
GB2602413ASecure Smart Dosing System With Automated Delivery, Measurement, And Management
CA3151052A1Secure Smart Dosing System With Automated Delivery, Measurement, And Management
CA3110239A1Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management
AU2020346957A1Secure Smart Dosing System With Automated Delivery, Measurement, And Management
IL291319ASecure Smart Dosing System With Automated Delivery, Measurement, And Management
US20210311056A1Self-Administered Infection Testing And Result Determination
WO2021051001A1Secure Smart Dosing System With Automated Delivery, Measurement, And Management
WO2020041430A1Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management
AU2019325522A1Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management

What are Vivera Pharmaceuticals key innovation segments?

What Technologies are Covered by Vivera Pharmaceuticals?

The chart below distributes patents filed by Vivera Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Vivera Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Vivera Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Vivera Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.